文献速递角膜与眼表疾病

莫拉菌性角膜炎的临床与微生物学特征

Clinical and microbiological characteristics of Moraxella keratitis.
PubMed 文献 · Br J Ophthalmol · 2019-02-01

采用MALDI-TOF鉴定亚种,非液化莫拉菌(39%)和腔隙莫拉菌(36%)与较大浸润、更多手术干预和更长治疗时间相关。结论强调该病初诊严重、对抗菌治疗反应慢、手术干预风险高且视力预后差,亚种鉴定对预后判断有价值。

要点

  • 既往眼部手术和糖尿病是莫拉菌性角膜炎最常见的局部与全身危险因素。
  • 非液化莫拉菌和腔隙莫拉菌与较大浸润、更多手术干预及更长治疗时间相关。
  • 该病初诊严重、治疗反应慢、手术干预风险高且视力预后差。

核心结论

  • 莫拉菌性角膜炎初诊时表现严重,对抗菌治疗反应慢,手术干预风险高且视力预后差。
  • MALDI-TOF亚种鉴定可区分非液化莫拉菌和腔隙莫拉菌与其他亚种的临床特征和预后差异。

研究设计与样本

  • 采用基质辅助激光解吸电离飞行时间质谱(MALDI-TOF)鉴定莫拉菌亚种。

主要发现

  • 既往眼部手术和糖尿病是最常见的局部和全身危险因素。
  • 初诊最常见表现为椭圆形旁中央浸润,平均直径4.2 mm。
  • 平均初诊和最终logMAR视力分别为1.307±0.74和0.99±1.01。
  • 9例(22%)患者需手术处理,包括穿透性角膜移植、角膜粘合或眼球内容物剜出。

关键数值与推荐

  • MALDI-TOF分析显示亚种分布:非液化莫拉菌16例(39%)、腔隙莫拉菌15例(36%)、奥斯陆莫拉菌4例(10%)、卡他莫拉菌2例(5%),4例(10%)亚种分析不确定。
  • 非液化莫拉菌和腔隙莫拉菌与初诊时较大浸润相关(p<0.05),并需要更多手术干预和更长治疗时间(p<0.001)。
  • 角膜上皮完全愈合平均时间32天(范围7-109天),局部抗生素治疗平均持续时间54天(范围9-124天)。

临床怎么用

  • 对莫拉菌性角膜炎应警惕其初诊严重性和缓慢的治疗反应,提前评估手术干预可能。
  • 考虑使用MALDI-TOF进行亚种鉴定,以辅助判断浸润大小、手术风险和疗程长短。

局限性

  • 单中心回顾性设计可能限制结果的普遍性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: To describe the risk factors, clinical features, bacterial subspecies characteristics and treatment outcomes of Moraxella keratitis in a single centre. METHODS: A retrospective review of all patients diagnosed with Moraxella keratitis between November 2012 and December 2017 at the Royal Victoria Eye and Ear Hospital, Dublin, Ireland was performed. Matrix-assisted laser desorption ionisation time-of-flight (MALDI-TOF) mass spectrometry was used to identify Moraxella subspecies. RESULTS: Forty-one cases of Moraxella keratitis were identified. Previous ocular surgery and diabetes were the most common local and systemic risk factors. The most common appearance on presentation was an oval-shaped paracentral infiltrate with a mean diameter of 4.2 mm. Mean presenting and final logarithm of minimal angle of resolution visual acuity were 1.307±0.74 and 0.99±1.01, respectively. Surgical procedures, including penetrating keratoplasty, corneal glueing or evisceration, were required to manage nine (22%) patients. Mean time to complete corneal epithelialisation was 32 (range, 7-109) days and mean duration of topical antibiotic therapy was 54 (range, 9-124) days. MALDI-TOF analysis revealed the following Moraxella subspecies: nonliquifaciens (16; 39%), lacunata (15; 36%), osloensis (4; 10%) and catarrhalis (2; 5%). In four cases (10%), subspecies analysis was inconclusive. M.nonliquifaciens and M. lacunata were associated with larger infiltrates on presentation (p<0.05), required more surgical intervention and longer treatment duration (p<0.001). CONCLUSION: In this large series of patients from Ireland, Moraxella keratitis was notable for its severity on presentation, slow response to antimicrobial therapy, high risk of surgical intervention and poor visual outcome. We have demonstrated the value of subspecies identification using MALDI-TOF by reporting significant differences in the clinical features and prognosis of M. nonliquifaciens and M. lacunata compared with other subspecies.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. McSwiney TJ, Knowles SJ, Murphy CC, et al. Clinical and microbiological characteristics of Moraxella keratitis. Br J Ophthalmol. 2019. PMID: 30709811. doi:10.1136/bjophthalmol-2018-313557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。